Clock Ticking on Linde-Praxair Merger

(c) Stepan Bormotov/Shutterstock
(c) Stepan Bormotov/Shutterstock

The 10-week acceptance period for the proposed $74 billion merger of Germany’s Linde with US rival Praxair began on Aug. 15 and will run through Oct. 24, Linde has announced.

If successful, the deal would create a global leader in the global gases market. With a market value of $75 billion at current exchange rates, $30 billion in annual sales and 88,000 employees, the combined company – which will trade as Linde – would pass the current leader, France’s Air Liquide.

With its own acquisition of Airgas in mid-2016 for $13 billion, Air Liquide knocked the standalone Linde out of first place.

Altogether 75% percent of Linde’s shareholders will have to tender their stock to the new company for the merger to succeed.  Praxair needs only a simple majority vote. 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.